Tradestie Institutional Equity Comparison Engine

BHFAN vs MET โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MET Overall Edge

MET Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MetLife, Inc. (MET) driven by superior Valuation, Momentum & Technical, Options & Structure while BHFAN counters with relative strength in Growth & Margin. Fundamentally, BHFAN trades at N/M Forward P/E with 18.4% operating margin (-52.7% YoY revenue) versus MET at 8.6x Forward P/E and 8.5% operating margin (+18.2% YoY). In options structure, BHFAN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MET sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MET
BHFAN N/M vs MET 8.6x Fwd P/E
Growth & Margin Winner BHFAN
Op Margin 18.4% vs 8.5% ยท YoY -52.7% vs +18.2%
Momentum & Technical Winner MET
1Y -29.0% vs +28.0% ยท 52W Pos 0% vs 72%
Options & Structure Winner MET
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (13th %ile IV)
BHFAN NASDAQ
Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C
Life Insurance
$9.18
-0.65% 1D
Market Cap N/A
1M Return -12.24%
1Y Return -29.0%
Forward P/E N/M
Unified AI Score
33.7 / 100 SELL
Tech 18.0 Fund 37.0 Flow 50.0 Mom 49.0
MET NYSE
MetLife, Inc.
Life Insurance
$95.67
-1.98% 1D
Market Cap $61.3B
1M Return -7.63%
1Y Return +27.97%
Forward P/E 8.6x
Unified AI Score
44.6 / 100 HOLD
Tech 47.0 Fund 51.0 Flow 52.0 Mom 56.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHFAN -29.0% MET +27.97% Spread: +56.97 pp (MET Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHFAN TTM Op. Margin: 18.4% MET TTM Op. Margin: 8.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHFAN vs MET. Trailing 12-month operating profitability (BHFAN 18.4% vs MET 8.5%) and valuation multiples (BHFAN N/M vs MET 8.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHFAN (4) vs MET (6)
Institutional Metric BHFAN MET Criterion Row Winner
Market Capitalization Scale N/A $61.3B Larger Scale MET
Trailing P/E Ratio Valuation 0.7x 12.8x Lower Multiple BHFAN
Forward P/E Ratio Valuation N/M 8.6x Lower Multiple MET
Revenue Growth (YoY) Growth -52.7% +18.2% Higher Growth MET
Operating Margin (TTM) Profitability 18.4% 8.5% Higher Margin BHFAN
Net Profit Margin Profitability 11.7% 6.2% Higher Margin BHFAN
Return on Equity (ROE) Capital Efficiency 11.9% 19.9% Higher ROE MET
52-Week Range Position Momentum 0% ($9โ€“$14) 72% ($67โ€“$107) Stronger Trend MET
Beta / 30D Volatility Risk Regime 0.36ฮฒ ยท 16% Vol 0.55ฮฒ ยท 28% Vol Lower Realized Risk BHFAN
Unified Institutional Score Composite Signal 33.7 / 100 (SELL) 44.6 / 100 (HOLD) Higher Composite MET

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHFAN vs MET Buy Guide
BHFAN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHFAN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MET UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live MET Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHFAN nor MET registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.